![EMBLA MEDICAL HF [CBOE]](/medias/logo_company/kCvKRHgn5kNqKLt.png "EMBLA MEDICAL HF [CBOE]"){kind=logo}
Ossur Hf : Transactions in relation to share buyback program
- 37
Announcement no. 53/2018
3 September 2018
Transactions in relation to share buyback program
On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018.
The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 28 February 2019. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.1% of the current share capital. The total consideration for shares purchased under the program shall not exceed USD 10 million.
The following transactions have been made under the program in week 26, the period 27 August 2018 - 31 August 2018:
| Transactions | ||||||
| Date | No. of shares | Avg. purchase price in DKK | Transaction value in DKK | |||
| 27 August 2018 | 12,972 | 29.40 | 381,394 | |||
| 28 August 2018 | 2,170 | 29.45 | 63,898 | |||
| 29 August 2018 | 11,234 | 29.22 | 328,259 | |||
| 30 August 2018 | 2,843 | 29.27 | 83,207 | |||
| 31 August 2018 | 2,115 | 28.71 | 60,730 | |||
| Total | 31,334 | 29.28 | 917,488 | |||
Össur has acquired 1,248,265 shares under the program at the average price of DKK 28.22. Following the above transactions Össur's holding of own shares is 5,366,996 corresponding to 1.25% of the Company's total share capital.
The share buyback program on Nasdaq Copenhagen is carried out in accordance with Regulation No. 596/2014 of the European Parliament and of the Council on market abuse ("MAR"), and the Commission delegated regulation No. 2016/1052.
Further information
David Hreidarsson, Investor Relations, [email protected], +354 515 1380
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail please register at http://www.ossur.com/investors
About Össur
Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that helps people live a life without limitations. Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapy. A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, EMEA and APAC, with additional distributors worldwide. www.ossur.com.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ossur Hf via Globenewswire
GlobeNewswire Europe, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
